{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:34:58Z","timestamp":1790440498538,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzen Municipality","doi-asserted-by":"publisher","award":["SZSM202411031"],"award-info":[{"award-number":["SZSM202411031"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"DOI":"10.1007\/s00428-026-04592-1","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T02:57:12Z","timestamp":1779764232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["CLDN18 identifies high-risk precursor lesions in gallbladder carcinogenesis: A study of the TFF2\u207a pseudopyloric metaplasia to intestinal metaplasia axis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9758-086X","authenticated-orcid":false,"given":"Qinqin","family":"Min","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyuan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyong","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9327-1261","authenticated-orcid":false,"given":"Mumin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"4592_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-022-00398-y","volume":"8","author":"JC Roa","year":"2022","unstructured":"Roa JC, Garc\u00eda P, Kapoor VK, Maithel SK, Javle M, Koshiol J (2022) Gallbladder cancer. Nat Rev Dis Primers 8:69. https:\/\/doi.org\/10.1038\/s41572-022-00398-y","journal-title":"Nat Rev Dis Primers"},{"key":"4592_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"4592_CR3","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.canlet.2021.09.004","volume":"521","author":"J Huang","year":"2021","unstructured":"Huang J, Patel HK, Boakye D, Chandrasekar VT, Koulaouzidis A, Lucero-Prisno DE Iii, Ngai CH, Pun CN, Bai Y, Lok V, Liu X, Zhang L, Yuan J, Xu W, Zheng ZJ, Wong MC (2021) Worldwide distribution, associated factors, and trends of gallbladder cancer: a global country-level analysis. Cancer Lett 521:238\u2013251. https:\/\/doi.org\/10.1016\/j.canlet.2021.09.004","journal-title":"Cancer Lett"},{"key":"4592_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.7326\/0003-4819-118-3-199302010-00005","volume":"118","author":"CH Grimaldi","year":"1993","unstructured":"Grimaldi CH, Nelson RG, Pettitt DJ, Sampliner RE, Bennett PH, Knowler WC (1993) Increased mortality with gallstone disease: results of a 20-year population-based survey in Pima Indians. Ann Intern Med 118:185\u2013190. https:\/\/doi.org\/10.7326\/0003-4819-118-3-199302010-00005","journal-title":"Ann Intern Med"},{"key":"4592_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.bbcan.2016.03.004","volume":"1865","author":"JA Espinoza","year":"2016","unstructured":"Espinoza JA, Bizama C, Garc\u00eda P, Ferreccio C, Javle M, Miquel JF, Koshiol J, Roa JC (2016) The inflammatory inception of gallbladder cancer. Biochim Biophys Acta 1865:245\u2013254. https:\/\/doi.org\/10.1016\/j.bbcan.2016.03.004","journal-title":"Biochim Biophys Acta"},{"key":"4592_CR6","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1053\/j.gastro.2017.04.005","volume":"153","author":"J Koshiol","year":"2017","unstructured":"Koshiol J, Gao YT, Dean M, Egner P, Nepal C, Jones K, Wang B, Rashid A, Luo W, Van Dyke AL, Ferreccio C, Malasky M, Shen MC, Zhu B, Andersen JB, Hildesheim A, Hsing AW, Groopman J (2017) Association of Aflatoxin and gallbladder cancer. Gastroenterology 153:488-494 e481. https:\/\/doi.org\/10.1053\/j.gastro.2017.04.005","journal-title":"Gastroenterology"},{"key":"4592_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.yexmp.2011.06.004","volume":"91","author":"Z Feng","year":"2011","unstructured":"Feng Z, Chen J, Wei H, Gao P, Shi J, Zhang J, Zhao F (2011) The risk factor of gallbladder cancer: hyperplasia of mucous epithelium caused by gallstones associates with p16\/CyclinD1\/CDK4 pathway. Exp Mol Pathol 91:569\u2013577. https:\/\/doi.org\/10.1016\/j.yexmp.2011.06.004","journal-title":"Exp Mol Pathol"},{"key":"4592_CR8","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.jhep.2020.11.033","volume":"74","author":"C Nepal","year":"2021","unstructured":"Nepal C, Zhu B, O\u2019Rourke CJ, Bhatt DK, Lee D, Song L, Wang D, Van Dyke AL, Choo-Wosoba H, Liu Z, Hildesheim A, Goldstein AM, Dean M, LaFuente-Barquero J, Lawrence S, Mutreja K, Olanich ME, Lorenzo Bermejo J, Ferreccio C, Roa JC, Rashid A, Hsing AW, Gao YT, Chanock SJ, Araya JC, Andersen JB, Koshiol J (2021) Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes. J Hepatol 74:1132\u20131144. https:\/\/doi.org\/10.1016\/j.jhep.2020.11.033","journal-title":"J Hepatol"},{"key":"4592_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41421-022-00445-8","volume":"8","author":"X Wang","year":"2022","unstructured":"Wang X, Liu C, Chen J, Chen L, Ren X, Hou M, Cui X, Jiang Y, Liu E, Zong Y, Duan A, Fu X, Yu W, Zhao X, Yang Z, Zhang Y, Fu J, Wang H (2022) Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma. Cell Discov 8:101. https:\/\/doi.org\/10.1038\/s41421-022-00445-8","journal-title":"Cell Discov"},{"key":"4592_CR10","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1365-2559.2008.03192.x","volume":"55","author":"RD Goldin","year":"2009","unstructured":"Goldin RD, Roa JC (2009) Gallbladder cancer: a morphological and molecular update. Histopathology 55:218\u2013229. https:\/\/doi.org\/10.1111\/j.1365-2559.2008.03192.x","journal-title":"Histopathology"},{"key":"4592_CR11","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1093\/annonc\/mdu006","volume":"25","author":"SG Barreto","year":"2014","unstructured":"Barreto SG, Dutt A, Chaudhary A (2014) A genetic model for gallbladder carcinogenesis and its dissemination. Ann Oncol 25:1086\u20131097. https:\/\/doi.org\/10.1093\/annonc\/mdu006","journal-title":"Ann Oncol"},{"key":"4592_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25012-9","volume":"12","author":"J Lin","year":"2021","unstructured":"Lin J, Peng X, Dong K, Long J, Guo X, Li H, Bai Y, Yang X, Wang D, Lu X, Mao Y, Sang X, Ji X, Zhao H, Liang H (2021) Genomic characterization of co-existing neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer. Nat Commun 12:4753. https:\/\/doi.org\/10.1038\/s41467-021-25012-9","journal-title":"Nat Commun"},{"key":"4592_CR13","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1097\/SLA.0000000000004482","volume":"276","author":"T Muraki","year":"2022","unstructured":"Muraki T, Pehlivanoglu B, Memis B, Reid MD, Uehara T, Basturk O, Pernicka JG, Klimstra DS, Jarnagin WR, Ito T, Hasebe O, Okaniwa S, Horigome N, Hisa T, Mittal P, Sarmiento JM, Maithel SK, Koshiol J, Tsai S, Evans D, Erkan M, Adsay V (2022) Pancreatobiliary maljunction-associated gallbladder cancer is as common in the West, shows distinct clinicopathologic characteristics and offers an invaluable model for anatomy-induced reflux-associated physio-chemical carcinogenesis. Ann Surg 276:e32\u2013e39. https:\/\/doi.org\/10.1097\/SLA.0000000000004482","journal-title":"Ann Surg"},{"key":"4592_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/his.14360","volume":"79","author":"JC Roa","year":"2021","unstructured":"Roa JC, Basturk O, Adsay V (2021) Dysplasia and carcinoma of the gallbladder: pathological evaluation, sampling, differential diagnosis and clinical implications. Histopathology 79:2\u201319. https:\/\/doi.org\/10.1111\/his.14360","journal-title":"Histopathology"},{"key":"4592_CR15","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1097\/PAS.0000000000000882","volume":"41","author":"T Muraki","year":"2017","unstructured":"Muraki T, Memis B, Reid MD, Uehara T, Ito T, Hasebe O, Okaniwa S, Horigome N, Hisa T, Mittal P, Freedman A, Maithel S, Sarmiento JM, Krasinskas A, Koshiol J, Adsay V (2017) Reflux-associated cholecystopathy: analysis of 76 gallbladders from patients with Supra-Oddi union of the pancreatic duct and common bile duct (pancreatobiliary maljunction) elucidates a specific diagnostic pattern of mucosal hyperplasia as a prelude to carcinoma. Am J Surg Pathol 41:1167\u20131177. https:\/\/doi.org\/10.1097\/PAS.0000000000000882","journal-title":"Am J Surg Pathol"},{"key":"4592_CR16","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/s0046-8177(96)90109-4","volume":"27","author":"II Wistuba","year":"1996","unstructured":"Wistuba II, Gazdar AF, Roa I, Albores-Saavedra J (1996) p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study. Hum Pathol 27:360\u2013365. https:\/\/doi.org\/10.1016\/s0046-8177(96)90109-4","journal-title":"Hum Pathol"},{"key":"4592_CR17","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nrc1429","volume":"4","author":"II Wistuba","year":"2004","unstructured":"Wistuba II, Gazdar AF (2004) Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer 4:695\u2013706. https:\/\/doi.org\/10.1038\/nrc1429","journal-title":"Nat Rev Cancer"},{"key":"4592_CR18","doi-asserted-by":"publisher","first-page":"8083","DOI":"10.1007\/s13277-015-4728-9","volume":"37","author":"A Yadav","year":"2016","unstructured":"Yadav A, Gupta A, Yadav S, Rastogi N, Agrawal S, Kumar A, Kumar V, Misra S, Mittal B (2016) Association of Wnt signaling pathway genetic variants in gallbladder cancer susceptibility and survival. Tumour Biol 37:8083\u20138095. https:\/\/doi.org\/10.1007\/s13277-015-4728-9","journal-title":"Tumour Biol"},{"key":"4592_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18102063","author":"H Kinoshita","year":"2017","unstructured":"Kinoshita H, Hayakawa Y, Koike K (2017) Metaplasia in the stomach-precursor of gastric cancer? Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms18102063","journal-title":"Int J Mol Sci"},{"key":"4592_CR20","first-page":"639","volume":"79","author":"PH Schmidt","year":"1999","unstructured":"Schmidt PH, Lee JR, Joshi V, Playford RJ, Poulsom R, Wright NA, Goldenring JR (1999) Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest 79:639\u2013646","journal-title":"Lab Invest"},{"key":"4592_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/path.6089","volume":"260","author":"JR Goldenring","year":"2023","unstructured":"Goldenring JR (2023) Spasmolytic polypeptide-expressing metaplasia (SPEM) cell lineages can be an origin of gastric cancer. J Pathol 260:109\u2013111. https:\/\/doi.org\/10.1002\/path.6089","journal-title":"J Pathol"},{"key":"4592_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202401227","volume":"12","author":"L He","year":"2025","unstructured":"He L, Zhang X, Zhang S, Wang Y, Hu W, Li J, Liu Y, Liao Y, Peng X, Li J, Zhao H, Wang L, Lv YF, Hu CJ, Yang SM (2025) H. Pylori-facilitated TERT\/Wnt\/\u03b2-Catenin triggers spasmolytic polypeptide-expressing metaplasia and oxyntic atrophy. Adv Sci (Weinh) 12:e2401227. https:\/\/doi.org\/10.1002\/advs.202401227","journal-title":"Adv Sci (Weinh)"},{"key":"4592_CR23","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1136\/gutjnl-2019-318930","volume":"69","author":"KA Bockerstett","year":"2020","unstructured":"Bockerstett KA, Lewis SA, Wolf KJ, Noto CN, Jackson NM, Ford EL, Ahn TH, DiPaolo RJ (2020) Single-cell transcriptional analyses of spasmolytic polypeptide-expressing metaplasia arising from acute drug injury and chronic inflammation in the stomach. Gut 69:1027\u20131038. https:\/\/doi.org\/10.1136\/gutjnl-2019-318930","journal-title":"Gut"},{"key":"4592_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124535","author":"W Hoffmann","year":"2020","unstructured":"Hoffmann W (2020) Trefoil factor family (TFF) peptides and their diverse molecular functions in mucus barrier protection and more: changing the paradigm. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21124535","journal-title":"Int J Mol Sci"},{"key":"4592_CR25","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1093\/carcin\/bgab093","volume":"42","author":"K Hasebe","year":"2021","unstructured":"Hasebe K, Yamaguchi J, Kokuryo T, Yokoyama Y, Ochiai Y, Nagino M, Ebata T (2021) Trefoil factor family 2 inhibits cholangiocarcinogenesis by regulating the PTEN pathway in mice. Carcinogenesis 42:1496\u20131505. https:\/\/doi.org\/10.1093\/carcin\/bgab093","journal-title":"Carcinogenesis"},{"key":"4592_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1128\/IAI.02039-05","volume":"75","author":"EA Kurt-Jones","year":"2007","unstructured":"Kurt-Jones EA, Cao L, Sandor F, Rogers AB, Whary MT, Nambiar PR, Cerny A, Bowen G, Yan J, Takaishi S, Chi AL, Reed G, Houghton J, Fox JG, Wang TC (2007) Trefoil family factor 2 is expressed in murine gastric and immune cells and controls both gastrointestinal inflammation and systemic immune responses. Infect Immun 75:471\u2013480. https:\/\/doi.org\/10.1128\/IAI.02039-05","journal-title":"Infect Immun"},{"key":"4592_CR27","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1038\/s41379-020-0520-5","volume":"33","author":"S Srivastava","year":"2020","unstructured":"Srivastava S, Huang KK, Rebbani K, Das K, Fazreen Z, Yeoh KG, Tan P, Teh M (2020) An LCM-based genomic analysis of SPEM, gastric cancer and pyloric gland adenoma in an Asian cohort. Mod Pathol 33:2075\u20132086. https:\/\/doi.org\/10.1038\/s41379-020-0520-5","journal-title":"Mod Pathol"},{"key":"4592_CR28","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41571-024-00874-2","volume":"21","author":"I Nakayama","year":"2024","unstructured":"Nakayama I, Qi C, Chen Y, Nakamura Y, Shen L, Shitara K (2024) Claudin 18.2 as a novel therapeutic target. Nat Rev Clin Oncol 21:354\u2013369. https:\/\/doi.org\/10.1038\/s41571-024-00874-2","journal-title":"Nat Rev Clin Oncol"},{"key":"4592_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16030679","author":"MC Mathias-Machado","year":"2024","unstructured":"Mathias-Machado MC, de Jesus VHF, J\u00e1come A, Donadio MD, Aruquipa MPS, Fogacci J, Cunha RG, da Silva LM, Peixoto RD (2024) Claudin 18.2 as a new biomarker in gastric cancer-What should we know? Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers16030679","journal-title":"Cancers (Basel)"},{"key":"4592_CR30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jcmgh.2019.03.003","volume":"8","author":"K Suzuki","year":"2019","unstructured":"Suzuki K, Sentani K, Tanaka H, Yano T, Suzuki K, Oshima M, Yasui W, Tamura A, Tsukita S (2019) Deficiency of Stomach-Type Claudin-18 in mice induces gastric tumor formation independent of H pylori infection. Cell Mol Gastroenterol Hepatol 8:119\u2013142. https:\/\/doi.org\/10.1016\/j.jcmgh.2019.03.003","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"4592_CR31","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/his.13797","volume":"74","author":"JA Espinoza","year":"2019","unstructured":"Espinoza JA, Riquelme I, Sagredo EA, Rosa L, Garc\u00eda P, Bizama C, Apud-Bell M, Leal P, Weber H, Benavente F, Vargas S, Romero D, Kalergis AM, Roa JC (2019) Mucin 5B, carbonic anhydrase 9 and claudin 18 are potential theranostic markers of gallbladder carcinoma. Histopathology 74:597\u2013607. https:\/\/doi.org\/10.1111\/his.13797","journal-title":"Histopathology"},{"key":"4592_CR32","doi-asserted-by":"publisher","first-page":"7624","DOI":"10.1158\/1078-0432.Ccr-08-1547","volume":"14","author":"U Sahin","year":"2008","unstructured":"Sahin U, Koslowski M, Dhaene K, Usener D, Brandenburg G, Seitz G, Huber C, T\u00fcreci O (2008) Claudin-18 splice variant 2 is a pan-cancer target suitable for therapeutic antibody development. Clin Cancer Res 14:7624\u20137634. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-08-1547","journal-title":"Clin Cancer Res"},{"key":"4592_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2021.1967080","volume":"10","author":"D Kyuno","year":"2022","unstructured":"Kyuno D, Takasawa A, Takasawa K, Ono Y, Aoyama T, Magara K, Nakamori Y, Takemasa I, Osanai M (2022) Claudin-18.2 as a therapeutic target in cancers: Cumulative findings from basic research and clinical trials. Tissue Barriers 10:1967080. https:\/\/doi.org\/10.1080\/21688370.2021.1967080","journal-title":"Tissue Barriers"},{"key":"4592_CR34","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/s0140-6736(23)00620-7","volume":"401","author":"K Shitara","year":"2023","unstructured":"Shitara K, Lordick F, Bang YJ, Enzinger P, Ilson D, Shah MA, Van Cutsem E, Xu RH, Aprile G, Xu J, Chao J, Pazo-Cid R, Kang YK, Yang J, Moran D, Bhattacharya P, Arozullah A, Park JW, Oh M, Ajani JA (2023) Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): A multicentre, randomised, double-blind, phase 3 trial. Lancet 401:1655\u20131668. https:\/\/doi.org\/10.1016\/s0140-6736(23)00620-7","journal-title":"Lancet"},{"key":"4592_CR35","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1038\/s41591-023-02465-7","volume":"29","author":"MA Shah","year":"2023","unstructured":"Shah MA, Shitara K, Ajani JA, Bang YJ, Enzinger P, Ilson D, Lordick F, Van Cutsem E, Gallego Plazas J, Huang J, Shen L, Oh SC, Sunpaweravong P, Soo Hoo HF, Turk HM, Oh M, Park JW, Moran D, Bhattacharya P, Arozullah A, Xu RH (2023) Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: The randomized, phase 3 GLOW trial. Nat Med 29:2133\u20132141. https:\/\/doi.org\/10.1038\/s41591-023-02465-7","journal-title":"Nat Med"},{"key":"4592_CR36","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/his.12662","volume":"67","author":"E Specht","year":"2015","unstructured":"Specht E, Kaemmerer D, S\u00e4nger J, Wirtz RM, Schulz S, Lupp A (2015) Comparison of immunoreactive score, HER2\/neu score and H score for the immunohistochemical evaluation of somatostatin receptors in bronchopulmonary neuroendocrine neoplasms. Histopathology 67(3):368\u2013377. https:\/\/doi.org\/10.1111\/his.12662","journal-title":"Histopathology"},{"key":"4592_CR37","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1023\/a:1022564027468","volume":"48","author":"AM Halld\u00f3rsd\u00f3ttir","year":"2003","unstructured":"Halld\u00f3rsd\u00f3ttir AM, Sigurdard\u00f3ttrir M, J\u00f3nasson JG, Oddsd\u00f3ttir M, Magn\u00fasson J, Lee JR, Goldenring JR (2003) Spasmolytic polypeptide-expressing metaplasia (SPEM) associated with gastric cancer in Iceland. Dig Dis Sci 48:431\u2013441. https:\/\/doi.org\/10.1023\/a:1022564027468","journal-title":"Dig Dis Sci"},{"key":"4592_CR38","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/his.15407","volume":"86","author":"MN Kinzler","year":"2025","unstructured":"Kinzler MN, Gretser S, Schulze F, Bankov K, Abedin N, Bechstein WO, Finkelmeier F, Zeuzem S, Reis H, Wild PJ, Walter D (2025) Expression of Claudin-18.2 in cholangiocarcinoma: a comprehensive immunohistochemical analysis from a German tertiary centre. Histopathology 86:640\u2013646. https:\/\/doi.org\/10.1111\/his.15407","journal-title":"Histopathology"},{"key":"4592_CR39","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00428-011-1092-z","volume":"459","author":"A Shinozaki","year":"2011","unstructured":"Shinozaki A, Shibahara J, Noda N, Tanaka M, Aoki T, Kokudo N, Fukayama M (2011) Claudin-18 in biliary neoplasms. Its significance in the classification of intrahepatic cholangiocarcinoma. Virchows Arch 459:73\u201380. https:\/\/doi.org\/10.1007\/s00428-011-1092-z","journal-title":"Virchows Arch"},{"key":"4592_CR40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/mog.0000000000000611","volume":"36","author":"C Louis","year":"2020","unstructured":"Louis C, Papoutsoglou P, Coulouarn C (2020) Molecular classification of cholangiocarcinoma. Curr Opin Gastroenterol 36:57\u201362. https:\/\/doi.org\/10.1097\/mog.0000000000000611","journal-title":"Curr Opin Gastroenterol"},{"key":"4592_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.canlet.2017.05.033","volume":"403","author":"K Takasawa","year":"2017","unstructured":"Takasawa K, Takasawa A, Osanai M, Aoyama T, Ono Y, Kono T, Hirohashi Y, Murata M, Sawada N (2017) Claudin-18 coupled with EGFR\/ERK signaling contributes to the malignant potentials of bile duct cancer. Cancer Lett 403:66\u201373. https:\/\/doi.org\/10.1016\/j.canlet.2017.05.033","journal-title":"Cancer Lett"},{"key":"4592_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/jcp-2024-209914","author":"SJ Ni","year":"2025","unstructured":"Ni SJ, Wang X, Yuan L, Dong H, Sun H, Tan C, Cai X, Jiang W, Sheng W, Xu M, Huang D (2025) Claudin18.2 expression in gallbladder cancer correlates with immune activation and a favourable prognosis. J Clin Pathol. https:\/\/doi.org\/10.1136\/jcp-2024-209914","journal-title":"J Clin Pathol"},{"key":"4592_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094909","author":"W Hoffmann","year":"2021","unstructured":"Hoffmann W (2021) Trefoil factor family (TFF) peptides and their links to inflammation: a re-evaluation and new medical perspectives. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22094909","journal-title":"Int J Mol Sci"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04592-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04592-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04592-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T02:57:19Z","timestamp":1779764239000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04592-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":43,"alternative-id":["4592"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04592-1","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Committee of the Shenzhen Hospital of Chinese Traditional Medicine and was conducted in accordance with the Declaration of Helsinki, with written informed consent obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}